# Desogestrel-Ethinylestradiol

## Mercilon \(21 tablets/box\)

| 藥物代碼 | OMERC |
| :--- | :--- |
| 適應症 | Oral Contraceptives |
| 副作用 | GI upsets, cholestatic jaundice; thrombosis, BP elevation; chloasma, erythema, nodosum, rash; headache, migraine, mood changes; breast tenderness, pain, enlargement, secretion; fluid retention, reduced glucose tolerance, change in body wt; intermenstrual bleeding, post-medication amenorrhea, changes in cervical secretion, increase in size of uterine fibromyomata, aggravation of endometriosis, vag infection. |
| 禁忌 | Thrombophlebitis, thromboembolic disorders, CV disease or past history of these conditions; severe hypertension; severe liver disorder, cholestatic jaundice, Rotor syndrome, Dubin-Johnson syndrome; known or suspected estrogen-dependent tumours; endometrial hyperplasia; undiagnosed vag bleeding; porphyria; hyperlipoproteinemia; history during pregnancy of severe pruritus or herpes gestationis. Pregnancy. |
| 藥物保存方式 | 室溫 |
| 用法用量 | 1 tab daily starting from the 1st day of menstruation For 21 days without interruption, then 7 tab-free days. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 不可使用 |
| 孕期用藥建議 | Contraindicated |
| 附帶說明 | Desogestrel \[18\] Ethinylestradiol Ethinylestradil \[18\] by book . micromedex : Teratogenicity/Effects in Pregnancy Rating Fetal risk cannot be ruled out. |
| 哺乳期用藥建議 | Contraindicated 哺乳期使用禁忌 |
| 附帶說明 | Desogestrel \[8\] ‧Evidence and/or expert consensus has demonstrated harmful infant effects when used during breastfeeding lEthinylestradiol Ethinylestradil \[8\] Evidence and/or expert consensus has demonstrated harmful infant effects when used during breastfeeding up to date: Lactation Enters breast milk/not recommended |
| 注射劑給藥建議途徑 | N/A |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

